StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.15−0.23 (-4.36%)

Close on Nov 17, 2026Market cap $278.95MP/E –Yield –

Eikon Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Eikon Therapeutics's total assets was $779.57M at Jun 30, 2026. For fiscal 2025 it was $594.73M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$594.73M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$779.57M–
Q1 FY2026Mar 31, 2026$850.83M–
Q4 FY2025Dec 31, 2025$594.73M–

More Eikon Therapeutics figures

See a number that looks wrong?